Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response

被引:567
作者
Missale, G
Bertoni, R
Lamonaca, V
Valli, A
Massari, M
Mori, C
Rumi, MG
Houghton, M
Fiaccadori, F
Ferrari, C
机构
[1] UNIV PARMA,CATTEDRA MALATTIE INFETT,I-43100 PARMA,ITALY
[2] AZIENDA OSPED PARMA,DIV MALATTIE INFETT & IMMUNOPATOL VIRALE,I-43100 PARMA,ITALY
[3] AZIENDA OSPED REGGIO EMILIA,DIV MALATTIE INFETT,I-42100 REGGIO EMILIA,ITALY
[4] UNIV MILAN,IRCCS,OSPED POLICLIN,CATTEDRA MED INTERNA,I-20122 MILAN,ITALY
[5] CHIRON CORP,EMERYVILLE,CA 94608
关键词
T cells; viremia; antigens; peptides; proliferative response;
D O I
10.1172/JCI118842
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The anti-viral T cell response is believed to play a central role in the pathogenesis of hepatitis C virus infection, Since chronic evolution occurs in > 50% of HCV infections, the sequential analysis of the T cell response from the early clinical stages of disease may contribute to define the features of the T cell response associated with recovery or chronic viral persistence, For this purpose, 21 subjects with acute hepatitis C virus infection were sequentially followed for an average time of 44 wk, Twelve patients normalized transaminase values that remained normal throughout the follow-up period; all but two cleared hepatitis C virus-RNA from serum, The remaining nine patients showed persistent viremia and elevated transaminases. Analysis of the peripheral blood T cell proliferative response to core, E1, E2, NS3, NS4, and NS5 recombinant antigens and synthetic peptides showed that responses to all hepatitis C virus antigens, except El, were significantly more vigorous and more frequently detectable in patients who hormalized transaminase levels than in those who did not, By sequential evaluation of the T cell response, a difference between the two groups of patients was already detectable at the very early stages of acute infection and then maintained throughout the follow-up period, The results suggest that the vigor of the T cell response during the early stages of infection may be a critical determinant of disease resolution and control of infection.
引用
收藏
页码:706 / 714
页数:9
相关论文
共 22 条
  • [1] TO C OR NOT TO C - THESE ARE THE QUESTIONS
    ALTER, HJ
    [J]. BLOOD, 1995, 85 (07) : 1681 - 1695
  • [2] PATIENTS WITH CHRONIC HEPATITIS-C HAVE CIRCULATING CYTOTOXIC T-CELLS WHICH RECOGNIZE HEPATITIS-C VIRUS-ENCODED PEPTIDES BINDING TO HLA-A2.1 MOLECULES
    BATTEGAY, M
    FIKES, J
    DIBISCEGLIE, AM
    WENTWORTH, PA
    SETTE, A
    CELIS, E
    CHING, WM
    GRAKOUL, A
    RICE, CM
    KUROKOHCHI, K
    BERZOFSKY, JA
    HOOFNAGLE, JH
    FEINSTONE, SM
    AKATSUKA, T
    [J]. JOURNAL OF VIROLOGY, 1995, 69 (04) : 2462 - 2470
  • [3] BOTTARELLI P, 1993, GASTROENTEROLOGY, V104, P580
  • [4] PERSISTENT HEPATITIS-C VIREMIA WITHOUT LIVER-DISEASE
    BRILLANTI, S
    FOLI, M
    GAIANI, S
    MASCI, C
    MIGLIOLI, M
    BARBARA, L
    [J]. LANCET, 1993, 341 (8843) : 464 - 465
  • [5] CYTOTOXIC T-LYMPHOCYTE RESPONSE TO HEPATITIS-C VIRUS-DERIVED PEPTIDES CONTAINING THE HLA A2.1 BINDING MOTIF
    CERNY, A
    MCHUTCHISON, JG
    PASQUINELLI, C
    BROWN, ME
    BROTHERS, MA
    GRABSCHEID, B
    FOWLER, P
    HOUGHTON, M
    CHISARI, FV
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (02) : 521 - 530
  • [6] POSSIBLE MECHANISM INVOLVING T-LYMPHOCYTE RESPONSE TO NONSTRUCTURAL PROTEIN-3 IN VIRAL CLEARANCE IN ACUTE HEPATITIS-C VIRUS-INFECTION
    DIEPOLDER, HM
    ZACHOVAL, R
    HOFFMANN, RM
    WIERENGA, EA
    SANTANTONIO, T
    JUNG, MC
    EICHENLAUB, D
    PAPE, GR
    [J]. LANCET, 1995, 346 (8981): : 1006 - 1007
  • [7] DOHERTY PC, 1992, ANNU REV IMMUNOL, V10, P123
  • [8] IDENTIFICATION OF IMMUNODOMINANT T-CELL EPITOPES OF THE HEPATITIS-B VIRUS NUCLEOCAPSID ANTIGEN
    FERRARI, C
    BERTOLETTI, A
    PENNA, A
    CAVALLI, A
    VALLI, A
    MISSALE, G
    PILLI, M
    FOWLER, P
    GIUBERTI, T
    CHISARI, FV
    FIACCADORI, F
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (01) : 214 - 222
  • [9] FERRARI C, 1994, HEPATOLOGY, V19, P286
  • [10] HOFFMANN RM, 1995, HEPATOLOGY, V21, P632, DOI 10.1016/0270-9139(95)90510-3